Vik Chopra
Stock Analyst at Wells Fargo
(1.2)
# 1665
Out of 5,240 analysts
29
Total ratings
58.33%
Success rate
11.51%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Globus Medical | Maintains: Overweight | 88 95 | 88.01 | 7.94% | 8 | Dec 11, 2024 | |
Masimo | Maintains: Overweight | 171 193 | 165.93 | 16.31% | 7 | Dec 11, 2024 | |
NeuroPace | Maintains: Overweight | 15 13 | 11.92 | 9.06% | 2 | Nov 13, 2024 | |
Envista Holdings | Initiates Coverage On: Equal-Weight | 20 | 18.86 | 6.04% | 1 | Oct 8, 2024 | |
Solventum | Maintains: Equal-Weight | 69 64 | 70.23 | -8.87% | 2 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 77 71 | 67.55 | 5.11% | 2 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 26 19 | 11.08 | 71.48% | 1 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 45 25 | 21.91 | 14.1% | 1 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 73 79 | 44.8 | 76.34% | 3 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 47 58 | n/a | n/a | 2 | Feb 10, 2023 |